Clinical trials
Active, not recruiting Phase 1 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 6 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 5 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| Baylor College of Medicine | 2 |
| Bellicum Pharmaceuticals | 2 |
| Innovent Biologics (Suzhou) Co. Ltd. | 2 |
| National Cancer Institute (NCI) | 2 |
| Seattle Children's Hospital | 2 |
| Byondis B.V. | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 32 |
| Leukemia | 8 |
| Lymphoma, Non-Hodgkin | 7 |
| Hodgkin Disease | 4 |
| Lymphoma, B-Cell | 4 |
| Recurrence | 4 |
| Immune System Diseases | 3 |
| Immunoproliferative Disorders | 3 |
| Lymphatic Diseases | 3 |
| Lymphoma, T-Cell, Cutaneous | 3 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.